NCI / SPORE Program
Gateway is partnering with the NCI to give SPORE recipients the opportunity to apply for supplemental funding for their early phase, innovative clinical trials. The Gateway funding could enable principal investigators and their respective institutions to start a new trial by adding an additional arm, add patient cohorts and/or new correlative analysis. Funding cannot duplicate scope of work of the SPORE award.
Grants are generally awarded for a 2-5 year period, with total award amounts generally ranging from $200,000 to $800,000.
The application process has a rolling Letter of Intent (LOI) submission which is aggregated four times a year.
- LOI submission – As part of a Letter of Intent (LOI), researchers answer basic questions about fit with Gateway’s mission and funding criteria, and provide contact information, high level information related to the proposed project, a concise summary of the study rationale, current standard of care, an overview of specific aims/objectives, and proposed research design/approach. LOIs are pre-generated/templated applications and must be submitted before the deadline listed on our GMS to be reviewed in upcoming cycle.
- LOI review – LOIs are assigned to scientists on Gateway’s Research and Grants Committee for peer review. The LOIs are reviewed within seven days after the LOI deadline has passed.
- Full Grant invitation to submit – Applicants who demonstrate that their project is in line with Gateway’s mission and are approved by the peer reviewers are invited to submit a Full Grant Application (FGA). Applicants will be given 4-5 weeks to complete a full grant application.
- Full Grant review – Once the full grant application is submitted to Gateway, each application is reviewed by the full Research and Grants Committee at a convened meeting and given a score per the NIH scoring model to indicate funding priority. The most promising grants are presented to Gateway’s Board of Directors.
- Full Grant approval – Gateway’s Board of Directors reviews the promising grants and determines final fiduciary approval of grant awards.